ArticleInternational journal of chronic obstructive pulmonary disease2026
Explainable Machine Learning for Predicting Deep Vein Thrombosis in Critically Ill Patients with COPD: Development and Multicenter External Validation.
Article in International journal of chronic obstructive pulmonary disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Deep vein thrombosis (DVT) is a frequent yet underrecognized complication in critically ill patients with chronic obstructive pulmonary disease (COPD). Existing risk assessment tools are not specifically tailored to this high-risk population. We aimed to develop and externally validate an interpretable machine-learning model for early prediction of DVT in ICU-admitted COPD patients. Methods: Adult COPD patients admitted to the ICU were identified from the MIMIC-IV database and randomly divided into training and internal validation cohorts. Eight machine-learning algorithms were constructed and compared. The best-performing model was externally validated in MIMIC-III and eICU cohorts. Model discrimination, calibration, and clinical utility were assessed using AUC, calibration plots, decision-curve analysis (DCA), and Brier scores. SHAP analysis was applied for global and individual interpretability. A web-based calculator was developed for clinical application. Results: Among 6,672 ICU patients with COPD, 462 (6.9%) developed DVT. XGBoost showed the best overall performance, with an AUC of 0.840 (95% CI 0.812-0.868) in the internal validation cohort and good calibration. External validation confirmed stable discrimination in both MIMIC-III and eICU cohorts. Model interpretation identified prolonged PTT, elevated RDW, reduced SpO Conclusion: We developed and externally validated an explainable machine-learning model for early prediction of DVT in ICU patients with COPD. By providing individualized risk estimates and interpretable explanations, this tool may help clinicians identify high-risk patients earlier and support more targeted thromboprophylaxis and imaging surveillance strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.